Harrow, Inc. (HROW)
38.62
-14.96
(-27.92%)
USD |
NASDAQ |
Mar 03, 16:00
38.65
+0.02
(+0.06%)
After-Hours: 20:00
Harrow Shareholders Equity (Quarterly) : 47.02M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 647.80M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Xeris Biopharma Holdings, Inc. | -0.861M |
| Stoke Therapeutics, Inc. | 308.10M |
| Vir Biotechnology, Inc. | 765.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 363.07M |
| Total Liabilities (Quarterly) | 316.41M |
| Debt to Equity Ratio | 5.357 |
| Current Ratio | 2.716 |
| Net Debt Paydown Yield | -0.67% |